accessibility menu, dialog, popup

UserName
Viewing profile as user:

Phenoxy compounds

Organic compounds that have one or more phenyl groups that are bonded to an oxygen with a radical electron; includes compounds with additional substitutions.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (4)
  • (1)
  • (2)

special interests

  • (5)

Search Within Results
Keyword Search:
1 – 7 of 7 results
1

eMolecules​ GSK269962 hydrochloride | 2095432-71-4 | MFCD31536773 | 50mg

Ambeed | GSK269962 hydrochloride | 50mg | 524993411 | A105790 | | 2095432-71-4 | MFCD31536773 | 607.070 | C29H31ClN8O5

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
2

Strem, An Ascensus Company CAS# 1447963-71-4. 100MG. 2-Diphenylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl, min. 98% PhCPhos
SDP

CAS# 1447963-71-4. 100MG. 2-Diphenylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl, min. 98%. PhCPhos Molecular Formula: C28H29N2P. Molecular Weight: 424.52. Color/Form: tan solid. Strem# 15-1125. www.strem.com/catalog/v3/15-1125/

ENCOMPASS
3

eMolecules​ ChemScene / 1-(2-(Cyclopropylmethoxy)-6-(4-methoxybenzyloxy)phenyl)ethanone / 100mg / 572307467 / CS-M1897 / 0.000 / 405239-71-6 / MFCD16039230 / 326.392 / C20H22O4

ChemScene / 1-(2-(Cyclopropylmethoxy)-6-(4-methoxybenzyloxy)phenyl)ethanone / 100mg / 572307467 / CS-M1897 / 0.000 / 405239-71-6 / MFCD16039230 / 326.392 / C20H22O4

ENCOMPASS_PREFERRED
4

Medchemexpress LLC N-(3-((3-(5-chlorothiophene-2-sulfonamido)-4-methoxyindazol-1-yl)methyl)benzyl)-2-hydroxy-2-methylpropanamide | 1240516-71-5 | 99.8% | 549.06 | C24H25ClN4O5S2 | 25 MG
SDP

GSK2239633A is a small-molecule CC-chemokine receptor 4 (CCR4) antagonist supplied for research use. It inhibits [125I]-TARC binding to human CCR4 with a reported pIC50 of 7.96 and shows activity in human CD4+ CCR4+ T-cells. The compound is provided as a solid with high reported purity and defined molecular formula and weight, suitable for in vitro pharmacology and analytical studies.

  • Allosteric CCR4 antagonist with reported pIC50 ~7.96.
  • Validated in vitro activity on human CD4+ CCR4+ T-cells.
  • High reported purity suitable for research assays.
  • Solid form, stable for analytical use.
  • Contains defined molecular formula and molecular weight for characterization.

ENCOMPASS_PREFERRED
5

Medchemexpress LLC N-[[3-[[3-[(5-chlorothiophen-2-yl)sulfonylamino]-4-methoxyindazol-1-yl]methyl]phenyl]methyl]-2-hydrox | 1240516-71-5 | MFCD30533311 | 99.8% | 549.06 g/mol | C24H25ClN4O5S2 | 100 MG
SDP

GSK2239633A is a small-molecule CCR4 antagonist used in research to inhibit [125I]-TARC binding to human CCR4 (reported pIC50 7.96). It is supplied as a high-purity solid with defined storage recommendations and high solubility in DMSO for assay preparation.

  • High purity suitable for research assays.
  • Selective CCR4 antagonistic activity (pIC50 7.96).
  • Solid form with recommended freezer storage.
  • High solubility in DMSO for stock preparation.
  • Molecular weight 549.06 g/mol and formula C24H25ClN4O5S2.
  • For research use only; not for human or diagnostic use.

ENCOMPASS_PREFERRED
6

Medchemexpress LLC HY-100183 50mg Medchemexpress, GSK2239633A CAS:1240516-71-5 Purity:>98%
SDP

Medchemexpress, HY-100183 50mg GSK2239633A CAS:1240516-71-5 GSK2239633A is a CC-chemokine receptor 4 ( CCR4 ) antagonist, which inhibits the binding of [ 125 I]-TARC to human CCR4 with a pIC 50 of 7.96 ± 0.11. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.

ENCOMPASS_PREFERRED
7

Medchemexpress LLC Futibatinib (TAS-120) | 1448169-71-8 | 418.45 g/mol | C22H22N6O3 | 100 MG
SDP

Futibatinib (TAS-120) is an orally bioavailable, irreversible fibroblast growth factor receptor (FGFR) inhibitor used in research to study FGFR-driven signaling and oncology models. It inhibits FGFR1-4 and retains activity against several FGFR2 mutants, making it a tool compound for in vitro and in vivo pathway inhibition studies.

  • Molecular weight: 418.45 g/mol.
  • CAS number: 1448169-71-8.
  • Chemical formula: C22H22N6O3.
  • Target: FGFR1-4, including mutant FGFR2 variants.
  • Potency: low-nanomolar IC50 values against FGFRs.
  • Typical applications: biochemical assays and cellular or animal studies of FGFR signaling.

ENCOMPASS_PREFERRED